Evidence map›Paper›PMID 40342104›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

[

Donglang Jiang, Zhaohui Chu, Yanfei Wu, You Zhang, Yao Liu, Qi Ge, Yue Gu, Zunguo Du, Yuanyuan Cheng, Xiwen Xu and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Donglang Jiang *Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Zhaohui Chu *Department of Oncology, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Yanfei Wu *Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, 200040, China.
You Zhang *Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Yao LiuDepartment of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Qi GeCentral Research Institute United Imaging Healthcare Group Co, Ltd, Shanghai, 201807, China.
Yue GuCentral Research Institute United Imaging Healthcare Group Co, Ltd, Shanghai, 201807, China.
Zunguo DuDepartment of Pathology, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Yuanyuan ChengDepartment of Pathology, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Xiwen XuDepartment of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Yuan HuangDepartment of Rehabilitation, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Dong XuDepartment of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai,, 200040, China.
Yihui GuanDepartment of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, 200040, China. guanyihui@hotmail.com.
Weijun WeiDepartment of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. wwei@shsmu.edu.cn.
Fang XieDepartment of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, 200040, China. fangxie@fudan.edu.cn.ORCID 0000-0003-2667-281X

Funding

STI2030-Major Projects 2022ZD0213800
6 · The paper itself

Abstract

purposeGallium-68 (

methodsParticipants with solid tumors who underwent [

resultsA total of 26 patients (mean age: 63 ± 10 years; 13 females) were included in the study. [

conclusion[

Indexed as

Antigens, NeoplasmCell Adhesion MoleculesGallium RadioisotopesGene Expression Regulation, NeoplasticHeterocyclic CompoundsHeterocyclic Compounds, 1-RingNeoplasmsPositron Emission Tomography Computed TomographyAdultAgedFemaleHumansMaleMiddle AgedTissue Distribution1,4,7-triazacyclononane-N,N',N''-triacetic acidAntigens, NeoplasmCell Adhesion MoleculesGallium RadioisotopesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingTACSTD2 protein, human[18F]FDG[68Ga]Ga-NOTA-T4ImmunopetSolid tumorTROP2 expression

Identifiers

PMID40342104

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.